Quantum-Si/$QSI
1D1W1MYTD1Y5YMAX
Capital at risk
About Quantum-Si
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
- Ticker
- $QSI
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 145
- Headquarters
- Branford, United States
- Website
- www.quantum-si.com
Quantum-Si Metrics
BasicAdvanced
$169M
-
-$0.46
3.25
-
Price and volume
Market cap
$169M
Beta
3.25
52-week high
$3.10
52-week low
$0.69
Average daily volume
2.4M
Financial strength
Current ratio
9.969
Quick ratio
9.359
Long term debt to equity
0.008
Total debt to equity
0.018
Profitability
EBITDA (TTM)
-87.36
Gross margin (TTM)
35.02%
Net profit margin (TTM)
-6,138.26%
Operating margin (TTM)
-5,742.06%
Effective tax rate (TTM)
0.10%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-25.72%
Return on equity (TTM)
-49.11%
Valuation
Price to revenue (TTM)
103.079
Price to book
0.94
Price to tangible book (TTM)
0.94
Price to free cash flow (TTM)
-1.766
Free cash flow yield (TTM)
-56.63%
Free cash flow per share (TTM)
-0.436
Growth
Revenue change (TTM)
-52.96%
Earnings per share change (TTM)
-29.47%
3-year revenue growth (CAGR)
51.78%
3-year earnings per share growth (CAGR)
-17.37%
What the Analysts think about Quantum-Si
Analyst ratings (Buy, Hold, Sell) for Quantum-Si stock.
Analyst projections of the future price of Quantum-Si stock.
Quantum-Si Financial Performance
Revenues and expenses
Quantum-Si Earnings Performance
Company profitability
Upcoming events
No upcoming events
Quantum-Si News
AllArticlesVideos
Funds containing Quantum-Si
AllUSDGBP
Fund name | Fund size | $QSI weighting |
|---|---|---|
iShares Nasdaq US Biotechnology$BTEC | $1.2B | 0.01% |
iShares Nasdaq US Biotechnology£BTEK | £865M | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.